EMEA-002275-PIP01-17
Key facts
| Active substance |
moxonidine
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0228/2018
|
| PIP number |
EMEA-002275-PIP01-17
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Abbott Laboratories Limited
Tel. +44 (0) 1628 644513 |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|